AXL and glioblastoma: We used as a targeting moiety for a miR-10b antagonist (anti-miR-10b), the GL21.T aptamer, an inhibitor ligand specific for the receptor tyrosine kinase (RTK) Axl [35], which is expressed in several tumours, including GBM, and also implicated in GSC maintenance [36].